<DOC>
<DOCNO>
EP-0001125
</DOCNO>
<TEXT>
<DATE>
19790321
</DATE>
<IPC-CLASSIFICATIONS>
C07D-501/59 C07D-277/46 C07D-277/42 C07D-499/06 A61P-31/00 C07D-501/06 <main>C07D-501/20</main> C07D-499/00 A61K-31/545 C07D-277/20 A61K-31/546 C07D-501/00 C07D-285/00 C07D-277/40 A61P-31/04 C07D-277/00 C07D-501/20 C07D-285/06 
</IPC-CLASSIFICATIONS>
<TITLE>
cephalosporin derivatives, processes for their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
fujisawa pharmaceutical cojp<sep>fujisawa pharmaceutical co. ltd.<sep>fujisawa pharmaceutical co., ltd. 3, doshomachi 4-chome higashi-kuosaka-shi osaka 541jp <sep>fujisawa pharmaceutical co. ltd. <sep>
</APPLICANT>
<INVENTOR>
chiba toshiyuki<sep>takasugi hisashi<sep>takaya takao<sep>tozuka zenzaburo<sep>tsuji kiyoshi<sep>chiba, toshiyuki<sep>takasugi, hisashi<sep>takaya, takao<sep>tozuka, zenzaburo<sep>tsuji, kiyoshi<sep>chiba, toshiyuki101-12, iwami, miyake-cho shiki-gunnarajp<sep>takasugi, hisashi2-12-7, kohamanishi suminoe-kuosakajp<sep>takaya, takao1-5-87, suimeidaikawanishijp<sep>tozuka, zenzaburo4-20-18, kamishindentoyonakajp<sep>tsuji, kiyoshi2-17-2, nagai-cho-naka sumiyoshi-kuosakajp<sep>chiba, toshiyuki<sep>takasugi, hisashi  <sep>takaya, takao<sep>tozuka, zenzaburo<sep>tsuji, kiyoshi<sep>chiba, toshiyuki101-12, iwami, miyake-cho shiki-gunnarajp<sep>takasugi, hisashi2-12-7, kohamanishi suminoe-kuosakajp<sep>takaya, takao1-5-87, suimeidaikawanishijp<sep>tozuka, zenzaburo4-20-18, kamishindentoyonakajp<sep>tsuji, kiyoshi2-17-2, nagai-cho-naka sumiyoshi-kuosakajp<sep>
</INVENTOR>
<ABSTRACT>
new cephem compounds of the formula    wherein r¹ is amino or protected amino,   a is lower alkylene which may be substituted  with oxo, hydroxy, amino, protected hydroxy  or protected amino,   r² is hydrogen, halogen or hydroxy, and   r³ is carboxy or functionally modified carboxy,  its nontoxic, pharmaceutically acceptable salt and a bioprecusor  thereof.  the invention also relates to a pharmaceutical composition  comprising, as an effective ingredient, the above compound  in association with a pharmaceutically acceptable,  substantially nontoxic carrier or excipient, and to a method for  treating an infectious disease caused by pathogenes, which  comprises administering the above compound to infected  human being or animals.  
</ABSTRACT>
</TEXT>
</DOC>
